ACCELERON PHARMA INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
ACCELERON PHARMA INC. had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $0 as of 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2021-02-25
- 2020-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $0.00.
- 2020-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $0.00.
- 2020-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $3.52M.
- 2020-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $3.30M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-25 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-05 |
| 2020-06-30 | $3.52M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $3.30M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.86M 10-K · filed 2021-02-25 |
| 2019-09-30 | $1.33M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $1.39M 10-Q · filed 2020-08-06 |
| 2019-03-31 | $1.61M 10-Q · filed 2020-05-11 |
| 2018-12-31 | $1.49M 10-K · filed 2021-02-25 |
| 2018-09-30 | $2.03M 10-Q · filed 2019-11-06 |
| 2018-06-30 | $1.69M 10-Q · filed 2019-08-05 |
| 2018-03-31 | $1.32M 10-Q · filed 2019-05-09 |
| 2017-12-31 | $2.24M 10-K · filed 2020-02-27 |
| 2017-09-30 | $1.93M 10-Q · filed 2018-10-30 |
| 2017-06-30 | $1.52M 10-Q · filed 2018-08-02 |
| 2017-03-31 | $1.29M 10-Q · filed 2018-05-08 |
| 2016-12-31 | $1.24M 10-K · filed 2019-02-27 |
| 2016-09-30 | $12.16M 10-Q · filed 2017-11-07 |
| 2016-06-30 | $11.37M 10-Q · filed 2017-08-03 |
| 2016-03-31 | $8.50M 10-Q · filed 2017-05-08 |
| 2015-12-31 | $17.19M 10-K · filed 2018-02-27 |
| 2015-09-30 | $8.06M 10-Q · filed 2016-11-03 |
| 2015-06-30 | $10.68M 10-Q · filed 2016-08-04 |
| 2015-03-31 | $13.70M 10-Q · filed 2016-05-05 |
| 2014-12-31 | $14.12M 10-K · filed 2017-03-01 |
| 2014-09-30 | $15.03M 10-Q · filed 2015-11-04 |
| 2014-06-30 | $21.51M 10-Q · filed 2015-08-06 |
| 2014-03-31 | $25.94M 10-Q · filed 2015-05-07 |
| 2013-12-31 | $30.75M 10-K · filed 2016-02-25 |
| 2013-09-30 | $16.53M 10-Q · filed 2014-11-07 |
| 2013-06-30 | $7.39M 10-Q · filed 2014-08-12 |
| 2013-03-31 | $6.96M 10-Q · filed 2014-05-15 |
| 2012-12-31 | $6.65M 10-K · filed 2015-03-02 |
| 2012-09-30 | $4.96M 10-Q · filed 2013-11-14 |
| 2012-06-30 | $5.09M 10-Q · filed 2013-11-14 |
| 2011-12-31 | $4.39M 10-K · filed 2014-03-17 |